VIKING GLOBAL INVESTORS LP 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:32 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 34,237,779 5.020% | -11,775,973 (-25.59%) | Filing |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 46,013,752 6.400% | -8,085,314 (-14.95%) | Filing |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% | -15,269,895 (-22.01%) | Filing |
| 2024-02-14 10:20 am Sale | 2023-12-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 69,368,961 8.600% | -5,869,739 (-7.80%) | Filing |
| 2023-06-26 5:05 pm Sale | 2023-06-22 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% | -13,000,000 (-14.73%) | Filing |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 88,238,700 12.800% | 88,238,700 (New Position) | Filing |